ANVS
Annovis Bio Inc
1.20$
+1.7%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 85.0% | |
| 62.2% | 56.4% | 40.1% | 79.2% | 88.0% | 75.8% | 83.2% | 79.8% | 88.9% | 92.7% | 87.5% | 85.0% | |
| 62.2% | 56.4% | 40.1% | 79.2% | 88.0% | 75.8% | 83.2% | 79.8% | 88.9% | 92.7% | 87.5% | 85.0% | |
| 34.9% | 175.9% | 142.9% | 134.7% | 50.8% | 33.2% | 10.0% | 14.6% | 23.5% | 20.1% | 80.8% | 119.3% | |
| 34.9% | 41.9% | 62.3% | 80.4% | 37.5% | 27.9% | 9.4% | 13.1% | 21.7% | 17.2% | 78.7% | 28.9% | |
| 18.8% | 12.7% | 52.6% | 67.3% | 28.5% | 16.6% | 5.1% | 4.5% | 12.3% | 12.3% | 32.5% | 15.1% | |
| 65.1% | -75.9% | -42.9% | -34.7% | 49.2% | 66.8% | 90.0% | 85.4% | 76.5% | 79.9% | 19.2% | -19.3% | |
| -861.2% | -1,080.1% | -1,424.8% | -2,305.5% | -898.1% | -968.4% | -525.1% | -683.3% | -895.2% | -776.5% | -1,116.2% | -890.0% | |
| 88.2% | 93.3% | 136.0% | 224.1% | 90.4% | 99.1% | 65.2% | 90.8% | 114.5% | 117.7% | 171.4% | 170.3% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.